IDEAYA Biosciences (IDYA) Earnings Date, Estimates & Call Transcripts $19.07 +0.25 (+1.33%) As of 04/24/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDEAYA Biosciences Earnings Summary Upcoming Earnings DateMay. 6Before Market OpensEstimatedConsensus EPS (Feb. 13) -$0.67 Actual EPS (Feb. 13) -$1.49 Missed By -$0.82 Actual Revenue (Feb. 13) $7.00MIDEAYA Biosciences issued Q4 2024 earnings on February 13, 2025, reporting an EPS of -$1.49, which missed the consensus estimate of -$0.67 by $0.82. Quarterly revenue was reported to be $7 million, below analyst estimates of $7 million. With a trailing EPS of -$3.30, IDEAYA Biosciences' earnings are expected to decrease next year, from ($3.07) to ($3.20) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)IDYA Upcoming EarningsIDEAYA Biosciences' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 12:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get IDEAYA Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IDEAYA Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIDYA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IDYA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. IDEAYA Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.68-$0.66-$0.67Q2 20252-$0.72-$0.70-$0.71Q3 20252-$0.78-$0.63-$0.71Q4 20252-$0.82-$0.75-$0.79FY 20258($3.00)($2.74)($2.87) IDEAYA Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------2/13/2025Q4 2024-$0.67-$1.49 -$0.82-$1.49$7.00M$7.00M11/4/2024Q3 2024-$0.63-$0.60+$0.03-$0.60$4.27M-8/6/2024Q2 2024-$0.54-$0.68 -$0.14-$0.68$4.46M-5/7/2024Q1 2024-$0.51-$0.53 -$0.02-$0.53$5.43M-2/20/2024Q4 2023-$0.47-$0.52 -$0.05-$0.52$8.84M$3.90M11/7/2023Q3 2023-$0.49-$0.46+$0.03-$0.46$8.14M$8.00M8/10/2023Q2 2023-$0.55-$0.50+$0.05-$0.50$4.89M$3.50M5/9/2023Q1 2023-$0.52-$0.49+$0.03-$0.49$5.38M$7.90M IDEAYA Biosciences Earnings - Frequently Asked Questions When is IDEAYA Biosciences's earnings date? IDEAYA Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on IDYA's earnings history. Did IDEAYA Biosciences beat their earnings estimates last quarter? In the previous quarter, IDEAYA Biosciences (NASDAQ:IDYA) missed the analysts' consensus estimate of ($0.67) by $0.82 with a reported earnings per share (EPS) of ($1.49). Learn more on analysts' earnings estimate vs. IDYA's actual earnings. How much revenue does IDEAYA Biosciences generate each year? IDEAYA Biosciences (NASDAQ:IDYA) has a recorded annual revenue of $7 million. How much profit does IDEAYA Biosciences generate each year? IDEAYA Biosciences (NASDAQ:IDYA) has a recorded net income of -$274.48 million. IDYA has generated -$3.30 earnings per share over the last four quarters. What is IDEAYA Biosciences's EPS forecast for next year? IDEAYA Biosciences's earnings are expected to decrease from ($3.07) per share to ($3.20) per share in the next year. More Earnings Resources from MarketBeat Related Companies Legend Biotech Earnings Date TG Therapeutics Earnings Date Blueprint Medicines Earnings Date Sarepta Therapeutics Earnings Date Axsome Therapeutics Earnings Date Nuvalent Earnings Date Verona Pharma Earnings Date Grifols Earnings Date Krystal Biotech Earnings Date ADMA Biologics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InWhy It May Be Time to Buy CrowdStrike Stock Heading Into EarningsCan IBM’s Q1 Earnings Spark a Breakout for the Stock? This page (NASDAQ:IDYA) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
